Infarco
Olave, 10, Pamplona, Navarra, 31010, Spain
Overview
Infarco, incorporated in 1964, is the parent company of a group of companies that covers different lines of business, mainly related to the pharmaceutical sector. Since its founding 54 years ago, Infarco has grown to become a business group that employs 1,900 people and reinvests most of its profits in the group's companies, boosting its development and innovation. In the last three years, it has invested 134 million euros in R & D & i and fixed assets. Always under the strictest measures of quality and safety, and thanks to the work and commitment of highly qualified professionals, the group companies offer a wide range of products and services.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Health Care
- Pharmaceutical
Investment portfolio
- 3P Biopharmaceuticals
Led · Equity · Jul 2014
3P Biopharmaceuticals is a company created and driven by a group of committed partners with support from the Government of Navarra through Sodena. The firm serves a future client portfolio composed mainly of established biotechnology companies and multinational bio-pharmaceutical firms. In July 2014 the company completed a €6 million capital increase to obtain resources for scaling its team and adapting its installations. The raise was intended to meet growing demand from its future customers and execute its strategic plan. The operation attracted Infarco as an industrial partner and majority shareholder, seen as reinforcing the regional biomedicine sector in Navarra. Infarco views the investment as part of a diversification and internationalization strategy to enter biotechnology.
Team
No current team members are available.